Member Info for Taff8

Ignore the spread can sell for 5.5p

Still 12bags to go then

The equipment used for this procedure costs in excess of $1M, and the treatment is expensive. On average, each lithotripsy procedure in the USA costs more than $13,000, and often the procedure must be repeated to break up stubborn stones. It is estimated that 29%¹ of the time lithotripsy fails, and the patient must undergo a surgical procedure. The cost of these failed lithotripsy procedures is therefore almost $2.3 billion per year.

Can't believe some here thinks a technology saving $2.3b year in USA alone will be sold for peanuts.

The equipment used for this procedure costs in excess of $1M, and the treatment is expensive. On average, each lithotripsy procedure in the USA costs more than $13,000, and often the procedure must be repeated to break up stubborn stones. It is estimated that 29%¹ of the time lithotripsy fails, and the patient must undergo a surgical procedure. The cost of these failed lithotripsy procedures is therefore almost $2.3 billion per year.

Wolves, yes I'm guessing but been investing in pharma for past 12yrs,so have good idea..

Can't believe this isn't already 12p,make no mistake this is huge news for £9m company, £80m+royalties min imo.

Wolves, most products never reach the market, big pharma wouldn't buy stonechecker if they thought it wouldn't make it to market, big gamble investing in pharma looks like IQAI have done it.

Can buy £10k@6.4 we're going to 12p today

Stonechecker is worth $100m/£80m easy, plus 5% royalties which will be £££millions revenue.

Market haven't noticed this yet, get in promise this will hit 20p in Coming days, cash and royalties from major.

This is fooking huge hold tight will be 20p in no time

Gotta be £100m

This is why I bought direct into pdsb, ugly side of aim investing.

What opportunities

Can say pdsb have said there in discussions with government and other pharmaceutical companies, remember the Brazil vaccine jv is funded by the Brazilian government.

Jonhy, along with the Oxford vaccine it the only other vaccine that gives antibodies and t-cells so expect fireworks.

Crypto Chris, was in tiz@47, sng@35 and ncyt@30p,im not in nsci but direct in pdsb, yes pdsb will min 5bag very soon.

Hopefully 1.30ish rns over the pond on pdsb

mg

KEYTRUDA is an anti-PD-1 therapy that works by increasing the ability of the body’s immune system to help detect and fight tumor cells. KEYTRUDA is a humanized monoclonal antibody that blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby activating T lymphocytes which may affect both tumor cells and healthy cells.

Merck has the industry’s largest immuno-oncology clinical research program. There are currently more than 1,200 trials studying KEYTRUDA across a wide variety of cancers and treatment settings. The KEYTRUDA clinical program seeks to understand the role of KEYTRUDA across cancers and the factors that may predict a patient's likelihood of benefitting from treatment with KEYTRUDA, including exploring several different biomarkers.